As of 2026-01-03, the Relative Valuation of Akoya Biosciences Inc (AKYA) is (27.98) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Akoya Biosciences Inc based on Relative Valuation is -2268.8%.
The range of the Relative Valuation is (28.47) - (27.71) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.9x - 33.1x | 30.0x |
| Forward P/E multiples | 26.7x - 29.1x | 28.8x |
| Fair Price | (28.47) - (27.71) | (27.98) |
| Upside | -2307.1% - -2248.1% | -2268.8% |
| Date | P/E |